Skip to content
10-Q

Quarterly Report

Odyssey Health, Inc. ODYY

0001683168-26-001695

← back to feed
Filed
Mar 12, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2026 · Mar 11, 2026 99.85M sh
Shares Diluted Q2 2026 · Jan 31, 2026 107.85M sh
Shares Diluted Q2 2026 · Jan 31, 2026 106.95M sh
Shares Diluted Q2 2026 · Jan 31, 2025 104.71M sh
Shares Diluted Q2 2026 · Jan 31, 2025 104.71M sh
Operating Cash Flow Q2 2026 · Jan 31, 2026 −$568.26K
Operating Cash Flow Q2 2026 · Jan 31, 2025 −$295.19K
Stockholders Equity Q2 2026 · Jan 31, 2026 −$10.6M
Stockholders Equity Q2 2026 · Oct 31, 2025 −$7.16M
Stockholders Equity Q2 2026 · Jul 31, 2025 −$6.95M
Stockholders Equity Q2 2026 · Jan 31, 2025 −$6.46M
Stockholders Equity Q2 2026 · Oct 31, 2024 −$6.28M
Stockholders Equity Q2 2026 · Jul 31, 2024 −$5.33M
Current Liabilities Q2 2026 · Jan 31, 2026 $11.32M
Current Liabilities Q2 2026 · Jul 31, 2025 $7M
Current Assets Q2 2026 · Jan 31, 2026 $721.3K
Current Assets Q2 2026 · Jul 31, 2025 $49.72K
Total Assets Q2 2026 · Jan 31, 2026 $721.3K
Total Assets Q2 2026 · Jul 31, 2025 $49.72K
Eps Diluted Q2 2026 · Jan 31, 2026 −$0.03
Eps Diluted Q2 2026 · Jan 31, 2026 −$0.04
Eps Diluted Q2 2026 · Jan 31, 2025 $0.00
Eps Diluted Q2 2026 · Jan 31, 2025 −$0.01
Eps Basic Q2 2026 · Jan 31, 2026 −$0.03
Eps Basic Q2 2026 · Jan 31, 2026 −$0.04
Eps Basic Q2 2026 · Jan 31, 2025 $0.00
Eps Basic Q2 2026 · Jan 31, 2025 −$0.01
Sga Expense Q2 2026 · Jan 31, 2026 $181.94K
Sga Expense Q2 2026 · Jan 31, 2026 $485.13K
Sga Expense restated Q2 2026 · Jan 31, 2025 $156.59K
Sga Expense restated Q2 2026 · Jan 31, 2025 $736.02K
Net Income Q2 2026 · Jan 31, 2026 −$3.6M
Net Income Q2 2026 · Jan 31, 2026 −$4.09M
Net Income Q2 2026 · Oct 31, 2025 −$483.45K
Net Income Q2 2026 · Jan 31, 2025 −$220.13K
Net Income Q2 2026 · Jan 31, 2025 −$1.24M
Net Income Q2 2026 · Oct 31, 2024 −$1.02M
Operating Income Q2 2026 · Jan 31, 2026 −$181.94K
Operating Income Q2 2026 · Jan 31, 2026 −$485.13K
Operating Income Q2 2026 · Jan 31, 2025 −$156.59K
Operating Income Q2 2026 · Jan 31, 2025 −$736.02K